SourceOne Global Partners announced that it has filed a federal lawsuit in the United States District Court in the Northern District of Illinois against KGK Synergize, Inc. (“KGK”). The lawsuit alleges that SourceOne’s Cholesstrinol™ family of heart-healthy formulas do not infringe on KGK patents and trademarks, and that KGK has engaged in unfair competition by threatening SourceOne with infringement lawsuits.
About SourceOne Global Partners
SourceOne Global Partners, headquartered in Chicago, IL, is a leading supplier of innovative, science-based, branded ingredients and proprietary formulas to the nutritional supplement, functional food & beverage, cosmetic, and animal nutrition markets.
SourceOne has assembled an impressive and enviable portfolio of complementary condition-specific ingredients that address the most pressing health concerns, including heart health, Type II diabetes, cognitive function, diet and energy, and general wellness.
SourceOne is recognized as a leader in delivering the best science nature has to offer through health solutions like the award-winning Cholesstrinol™ Family of Heart Healthy Formulas, OmegaChoice™ Concentrated Omega-3 Essential Fatty Acids (EFAs), CoQsource® Bio-Enhanced Coenzyme Q10, and SterolSource® Phytosterols. The SourceOne product line continues to expand and also includes tocotrienols and tocopherols, palm carotenoids, citrus flavonoids, tongkat ali, Vitamin D, green tea, resveratrol, chondroitin, and more.